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Abstract Fetal cardiac interventions are new and rela-
tively unknown investigational options for modifying
congenital heart disease in utero. Techniques for safer
access to the fetus must be improved, and selection cri-
teria for patients for whom these procedures are
potentially beneﬁcial must be developed. Currently,
antenatal cardiac intervention attempts are being made
to either prevent or reverse hydrops in fetuses with
cardiac valve disease or outﬂow tract obstruction or to
recruit hypoplastic ventricles. Most important are early
detection and referral of these fetuses, thereby enabling
timely procedures with improved outcomes. However,
performing successful fetal cardiac interventions re-
quires multidisciplinary collaboration between obstetri-
cians, pediatric cardiologists, pediatric cardiac surgeons,
and anesthesiologists, as each discipline provides speciﬁc
skills for these critically ill babies.
Keywords Congenital heart disease Æ Fetus Æ Antenatal
balloon valvuloplasty
Introduction
Congenital heart disease (CHD) is the most common
serious congenital defect in humans, occurring as fre-
quently as 1 in 100–150 live births [1]. Most forms of
congenital heart defects relate to abnormal morpho-
genesis and patterning during development [1–8].
During the 1980s and 1990s, remarkable advances in
echocardiographic transducers, improved crystal
technology, enhanced digital processing of ultrasound
signals, and expanding operator skills resulted in an
increased ability to diagnose CHD long before birth
[8–13].
Because of imaging diﬃculties encountered during
the earliest weeks of gestation, fetal echocardiographic
diagnosis of CHD is usually accomplished only during
the 2nd and 3rd trimesters of pregnancy. However, with
improved technology and techniques, most major
structural heart defects can be diagnosed accurately
enough from the late 1st trimester [10–12].
Several studies have proven that prenatal diagnosis of
critical CHD such as hypoplastic left heart syndrome
(HLHS) and transposition of great arteries not only
improves the preoperative condition of neonates with
these lesions but also signiﬁcantly reduces intraoperative
and postoperative morbidity and mortality [14, 15].
Additionally, early knowledge of these conditions prior
to birth permits a better understanding of the progres-
sion of human heart malformations [8–18].
Infants with HLHS or right heart syndrome or other
malformations with a single ventricle physiology and
associated hypoplasia of the great arteries continue to be
a challenge in terms of survival. However, timely pre-
natal diagnosis, perinatal stabilization, and improve-
ments in surgical technique and perioperative care
account for a substantial increase in survival after pro-
cedures for complex lesions. Improved results have been
reported with stage-one palliation of HLHS with the
modiﬁed Norwood procedure and earlier performance
of a stage-two bidirectional cavopulmonary anastomosis
or a hemi-Fontan operation and have demonstrated
more favorable outcomes for postnatal staged recon-
structive palliation of HLHS or comparable malforma-
tions [15, 17–25].
However, some centers are already exploring new
minimally invasive therapeutic options with a view to in-
utero cardiac palliation [26–33]. The upcoming expan-
sion of fetal cardiac interventions to ameliorate critically
progressive fetal cardiac lesions intensiﬁes the need to
address issues about the adequacy of assessment and
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patient selection as well as the safety of those who un-
dergo these novel procedures.
Minimally invasive techniques
Despite remarkable advances, the number and type of
fetal abnormalities found by ultrasound and classiﬁed as
‘‘potentially treatable’’ by in-utero interventions are still
limited [33–36]. The most common noncardiac anoma-
lies for which invasive fetal therapy is currently being
considered are myelomeningocele, sacrococcygeal tera-
toma, obstructive uropathy, and malformations of the
lungs or the adjacent structures (such as diaphragmatic
hernia) [34–41]. It is noteworthy that despite the ad-
vances in prenatal diagnosis, studies on prenatal animal
model interventions have lagged years behind and still
remain limited [26–31, 33–38]. Ongoing evaluation of the
eﬃcacy of these still investigational techniques is re-
quired so that appropriate selection of fetuses for in-
utero surgery can be made.
The timing and concepts of intrauterine intervention
are now being reconsidered [27–42]. Keyhole instru-
ments and catheters and three-dimensional optics and
imaging modes make it possible to perform intricate
intrauterine procedures with a precision that one could
have achieved only through open hysterotomy in the
past.
Accuracy of diagnosis and patient selection
Despite recent advances, prenatal detection and accu-
racy of CHD diagnosis still remain problematic; this
situation is compounded by the diﬃculties of assessing
the adequacy of ventricular size and function with a view
to future suitability for biventricular or univentricular
repair in some forms of CHD [43–46]. Some cardiac
lesions may evolve during pregnancy, so clariﬁcation of
the implications of fetal cardiac ﬁndings may need to be
delayed until later in gestation [12, 25, 26, 32, 33, 43–47].
There have been many studies on the accuracy of ante-
natal diagnosis of fetal cardiac malformations, but
overall, most of the false negative ﬁndings occurred in
hearts with multiple lesions at early gestation. These
were diﬀerences that did not signiﬁcantly inﬂuence the
prognosis for the fetus, as the correctly identiﬁed prin-
cipal cardiac defect allowed a comprehensive prediction
of disease severity in most cases [8, 9, 24, 26, 33, 47–49].
Reliable antenatal predictive criteria for critically
progressive CHD justifying experimental fetal cardiac
surgery still have to be established. A possible deﬁnition
of critically progressive valvular disease could be the
situation of a primarily biventricular heart progressively
deteriorating into a univentricular anatomy due to
increasing hypoplasia of one ventricular chamber. This
would apply both to fetuses with critical pulmonary
stenosis with intact ventricular septum deteriorating to
pulmonary atresia as well as for fetuses with critical
aortic stenosis and progressive hypoplasia of the left
ventricle (Figs. 1, 2, 3). Unfortunately, the results of
attempted intrauterine transcatheter relief techniques for
left ventricular outﬂow tract obstruction or aortic valve
stenosis have been inconsistent and mostly discouraging
so far [16, 17, 26, 28, 31–33, 50, 51]. However, consid-
ering that the intrauterine evolution of some forms of
congenital heart defects continues to have signiﬁcant
morbidity and mortality both in utero and in the early
postnatal period, there seem to be numerous good
clinical reasons to further assess the role of prenatal
surgical approaches for ameliorating these conditions.
Fetal cardiac intervention
Although fetal cardiac intervention is currently not yet a
conventional alternative to neonatal repair, there have
been some reported successes in technique for in-utero
cardiac approaches [8, 16–18, 26, 28–33]. Percutaneous
ultrasound-guided balloon valvuloplasty techniques
have resulted in technical success in several human fe-
tuses with severe aortic or pulmonary valve obstruc-
tions; however, a conclusive survival ﬁgure for this
investigational procedure on possibly lethal congenital
heart anomalies is not appropriate in the current stage.
In most cases where in-utero valvuloplasty proce-
dures have been performed and have been technically
successful, there has been limited or no increase in
ejection fraction and only a little change in ventricular
end diastolic volume, but the period over which the fe-
tuses were studied prenatally was relatively short [8, 26,
28, 30–33, 44, 50, 51, 52]. The authors have speculated
that this inappropriate ventricular growth might be due
to the relatively advanced gestational age of the fetuses
Fig. 1 Example of an abnormal four-chamber view of a fetal heart
at 24 weeks’ gestation with severe pulmonary stenosis, a smaller
right ventricle obscured by hypertrophied ventricular walls, and an
intact ventricular septum
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at the time of intervention and suggest an earlier yet
more diﬃcult and hazardous intrauterine approach for
future cases. In view of the early mortality rate (20–30%
within the ﬁrst 24 h after the procedure) and the
constantly improving results of the Norwood procedure
at major institutions, some authors feel that prenatal
procedures are less justiﬁable [28, 33, 44, 50, 51]. Work is
in progress in animal models to improve fetoscopic
approaches guided by transesophageal or intraamniotic
fetal echocardiography, which improves the imaging
when the balloon catheter is inside the fetal heart, but
understandably, this approach has not yet been used in
the human fetus [27–34]. Further modiﬁcation and
miniaturization of new materials such as cutting balloon
catheters combined with future improvement in
transcatheter techniques oﬀer promise in reducing the
risks (Fig. 4) of intrauterine cardiac surgery techniques
[26–33].
Neonatal balloon valvuloplasty
During the last two decades, neonatal balloon valvu-
loplasty of critical aortic and pulmonary stenosis has
become the treatment of choice for the majority of these
patients [53–56]. In children with critical pulmonary
stenosis, mortality of the neonatal intervention is well
below 5% [56]. Successful balloon valvuloplasty of
critical pulmonary and aortic stenosis has been per-
formed in premature infants with birth weights well
below 2000 g [53, 54, 56]. Therefore, if fetal echocardi-
ography provides clear evidence of deteriorating hemo-
dynamics, premature delivery by cesarean section can be
an option in the 3rd trimester to allow neonatal inter-
ventional treatment of critical stenoses with impending
cardiac decompensation. This treatment should be re-
stricted, however, to centers with extensive experience in
the perinatal treatment of children with CHD. The
possible risks and beneﬁts for the child would have to be
weighed on a case-to-case basis.
Limitations and shortcomings
In-utero balloon valvuloplasty has been performed as a
means of improving the perinatal condition of aﬀected
infants [26, 28, 33, 44, 50, 51]. Postnatal balloon aortic
valvuloplasty is a widely accepted treatment modality
and represents the procedure of choice in many units for
children of all ages with congenital valvular aortic ste-
nosis [53, 56–59]. The growing fetus who would subse-
quently require a postnatal balloon aortic valvuloplasty
presents a challenge to the pediatric cardiologist or
cardiac surgeon to provide an early treatment that ide-
ally will allow compensatory growth even before birth.
The current inability to securely demonstrate a beneﬁt of
Fig. 2 In the color-ﬂow map imaged for the same fetus as in Fig. 1,
a blue jet of tricuspid regurgitation can be visualized
Fig. 3 Transuterine intraventricular needle entry in a fetus at 24
weeks’ gestation with critical aortic stenosis
Fig. 4 Pathological specimen of a chick embryo showing some
minor degree of structural damage after transamniotic intracardiac
access 3 days prior to hatching
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prenatal balloon valvuloplasty on the perinatal outcome
of babies with severe aortic stenosis may result from at
least three factors:
1. The inﬂuence of factors, such as optimized postnatal
operative technique according to anatomic subtypes,
on mortality and postinterventional course may
outweigh lesser beneﬁts achieved by prenatal relief of
outﬂow obstruction. For example, postnatal studies
on aortic valve repair and replacement after balloon
valvuloplasty for congenital aortic stenosis in chil-
dren have shown anatomic variables to be determi-
nants of interventional results [53, 57–59]. Better
prenatal predictive parameters will be needed to al-
low prenatal interventions to be properly targeted.
2. Due to the multicenter and retrospective nature of the
analysis, the absence of uniform criteria for fetal
selection, inadequate standardization of equipment
for these ‘‘pioneer procedures,’’ and small patient
numbers, existing studies are not yet able to assess the
short- and potential long-term beneﬁts of fetal car-
diac valvuloplasty.
3. The impact of supplementary lesions (for instance,
mitral stenosis in patients with aortic stenosis) or a
general (genetic) programming for ventricular hypo-
plasia that very well may exist in some fetuses can
make it oversimplistic to view relief of valve
obstruction as an adequate solution in many cases.
Until the beneﬁts of in-utero valvuloplasty attempts
are determined by well-controlled clinical trials, these
techniques remain investigational. Physicians and their
patients who are considering these procedures must be
made fully aware of the potential risks to both mother
and fetus, such as preterm delivery (from membrane
rupture or labor) and oligohydramnios with resulting
pulmonary hypoplasia. Additionally, we are concerned
that as obstetricians become more and more conﬁdent
with their keyhole instrumentation for intrauterine ap-
proaches, cardiac interventions might be undertaken
under the guise of ‘‘last-ditch eﬀorts’’ at various insti-
tutions that have little expertise in relevant catheter
techniques. Extensive informed parental counseling
about alternative postnatal options for treatment re-
mains critical. Few postnatal cardiac defects are cur-
rently untreatable, and a balanced view of options
requires counseling by a fetal/pediatric cardiologist
familiar with current postnatal surgical and interven-
tional options as well as outcomes. Ideally, the fetal/
pediatric cardiologist should serve as a constant member
of the perinatal team planning this procedure.
Counseling
Currently, parents who receive an early prenatal diag-
nosis of a cardiac lesion that may progress in severity
and that might require postnatal univentricular surgical
palliation often opt for termination or supportive care
after counseling. This points to the extremely diﬃcult
clinical and psychological course when surgical inter-
vention is undertaken [9, 43, 45, 51]. The uncertain
prognoses for these prenatally diagnosed lesions should
be explained to parents as early as possible to ensure
that they are in a position to make a fully informed
decision about future management of the disorder.
When counseling these families in early pregnancy for
continuation of the pregnancy, we should always men-
tion the possibility of evolution of these cardiac lesions
during later pregnancy, as it is important that parents
understand that there are several ‘‘hazards’’ that their
fetus and later neonate might face even before reaching
palliative postnatal surgery. The pediatric cardiologist is
vital in the counseling process of these families no matter
how early the diagnosis of fetal cardiac disease is made,
as not all lesions behave similarly or have the same
potential for progression. The prognostic evaluations
and available prenatal and postnatal surgical options
should be explained, modiﬁed, and updated accordingly
as they constantly change in individual categories [11,
12, 19–23, 26, 30–33, 60, 61]. Parents who are consid-
ering prenatal fetal cardiac intervention should be made
aware of its investigational nature and the potential risks
to both mother and fetus, and then they should be fully
supported in their decision, whatever their choice is.
Conclusion
With the help of 1st-trimester fetal echocardiography,
we are constantly gaining new insights into the ‘‘wors-
ening’’ progressive pathophysiology of fetal cardiac le-
sions during pregnancy [1–13]. Through innovations in
congenital heart surgery and intrauterine interventions,
as well as critical review of accepted perinatal manage-
ment strategies, the outlook for fetuses with congenital
heart lesions continues to improve year by year.
Numerous reports have demonstrated that morbidity
and mortality after staged palliation of HLHS or com-
parable malformations have improved dramatically and
should have a favorable impact on perinatal counseling
for HLHS or its variants [14–25].
Antenatal fetal heart surgery is no more than a the-
oretical alternative to postnatal repair in the human at
present. Potential indications for fetal balloon valvu-
loplasty include heart defects that after progression may
evolve into one-ventricle (univentricular) pathology [26–
33]. Early results are still likely to be ambiguous, but in
the proper hands and with long-term follow-up and
further experience, the issues of timing and selection
may be overcome.
Having observed the advances of the last years, we
anticipate that within 10 years, advances in cardiac
imaging and in-utero cardiac intervention technologies
will make it possible to substantially alter the care and
prognosis of the fetus with CHD. We hope that this
review contributes to a more balanced understanding of
what future fetal cardiac diagnosis and intervention
eﬀorts can and cannot achieve.
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